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Introduction
Gynaecological cancer surgery for ovarian malignancy is
performed to stage the disease in the early stage and to
undertake optimal cytoreduction in the advanced stage.
Recovery of these patients from major surgery requires
extensive medical and nursing input, as they usually have
large abdominal incisions and extensive dissection.1
However, a rapid recovery is imperative to start timely
adjuvant therapy, which is largely dependent on the
prevention, the early detection and the prompt treatment
of major intra- and post-operative complications.
The traditional peri-operative surgical practices include
overnight fasting, bowel preparation, nasogastric (NG)
tube, peritoneal drain insertion, and antimicrobial and
thrombi-embolic prophylaxis to prevent infections and
complications. The introduction of enhanced recovery after
surgery (ERAS) programmes in the 1990s in Denmark
changed the concept of peri-operative care.2 It was first
used for patients undergoing colorectal surgery.
Afterwards, it was adopted in other surgical disciplines,
such as orthopaedics, gynaecology and urology.3,4 The key
elements common to all ERAS pathways include pre-
operative patient education, reduction of pre-operative
fasting, omission of bowel preparation, peri-operative
normovolemia, limited use of NG tubes and drains, early
removal of urinary catheters, aggressive multimodal
analgesia to minimise opiate consumption, early post-
operative mobilisation and early oral nutrition.5,6
These innovations in practices have reduced morbidities
associated with these major surgeries and have shortened
the recovery time without adding to complications.7 To our
knowledge, no study from Pakistan is available that
assesses the benefits and safety of ERAS protocol in
patients with surgical management of ovarian cancer.
The current study was planned to compare the peri-
operative practices and complications in ovarian cancer
patients undergoing upfront surgery for primary disease
under the traditional practices and the ERAS protocol.
Patients and Methods
The retrospective cross-sectional study was done at the
gynaecology departments of St Georges Hospital (SGH),
National Health Trust (NHS), London, United Kingdom, and
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the Aga Khan University Hospital (AKUH), Pakistan, and
comprised data of an equal number of ovarian cancer
patients from each centre who underwent ovarian cancer
surgery from January 2015 to December 2016. Data
included pertained to patients having undergone primary
cytoreductive surgery for advanced stage ovarian cancer
determined by International Federation of Gynaecology
and Obstetrics (FIGO) stages III and IV. Data related to those
having undergone surgical treatment for recurrence of
ovarian cancer and those who had neoadjuvant
chemotherapy was excluded. The sample was raised using
purposive sampling at both hospitals.
The target population was about 200 patients at each
centre, but, as it was a clinical audit, a snapshot sample of
25% gave 95% degree of confidence that the sample was
representative of the target population.8 Data was retrieved
from electronic database and charts, and was noted using
a pre-designed structured proforma.
SGH patients formed the ERAS group, while AKUH patients
formed the non-ERAS group, based on institutional
practices. Independent variables included baseline
demographics, like age, body mass index (BMI) and medical
co-morbidities, while peri-operative data included bowel
preparation, duration of surgery, estimated blood loss,
bowel movement, mobilisation, length of stay,
complications, etc. The dependent variables were length of
hospital stay and post-operative complications. Length of
stay was defined as the number of days spent in the
hospital; from the first post-operative day till discharge.
Post-operative complications included wound infection,
which was defined on the basis of wound discharge and
dehiscence, fever, paralytic ileus, electrolyte imbalance,
thromboembolic phenomenon, and re-admission within
14 days of discharge.
Data was analysed using SPSS 19. Comparisons were made
between non-ERAS and ERAS groups using chi-square test
for categorical variables and Fisher’s exact test where
appropriate. Student t test was used to compare
continuous variables. P< 0.05 was considered statistically
significant.
Results
Of the 100 patients, there were 50(50%) in each group.
Baseline variables were comparable except for diabetes
which was more prevalent in the local group (p=0.03)
(Table 1).Patients were kept nil-per-oral (NPO) for longer
periods in the non-ERAS group compared to the ERAS
group; for solids 48h versus 6h, and for liquids 12h versus
2h. Mechanical bowel preparation was performed in
47(94%) of patients in the non-ERAS group compared to
1(2%) in the ERAS group. Prophylactic use of antibiotics was
practised in the ERAS group where 22(43.7%) patients
received 3 doses of antibiotics post-operatively in addition
to the intra-operative dose. In the non-ERAS group, all
patients received antibiotics intra-operatively and post-
operatively for 7 days. The use of peritoneal drains and NG
tubes was significantly higher in the non-ERAS group
(p<0.05).
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Table-1: Demographic characteristics.
UK (ERAS group) Pakistan(Non-ERAS group) p-value
Mean Age and Range(years) 61.4 ±12.47 (36-92) 54.88±12.54 (29-80) 0.84
Mean BMI(kg/m2) 
and  range 27.1±5.36 (21-39) 29.8±7.09 (34-53) 0.23
Co-morbidity = n (%) 
Hypertension 25(50) 25(50) 1.0
Diabetes Mellitus 5(10) 14(28) 0.03*
Respiratory (%) 7(14) 2(4) 0.15
Cardiac (%) 4(8) 2(4) 0.6
Renal (%) 2(4) 0(0) -
UK: United Kingdom, ERAS: Enhanced recovery after surgery, BMI: Body mass index.
Table-2: Peri-operative practices.
UK (ERAS Pakistan(Non- p-value
Group =n (%)) ERASgroup =n(%))
Preoperative preparation
Carbohydrate loading = n (%) 50(100) 0(0) .0001
Nil per oral (Hours)
For solids 6 48 .0001
For liquids 2 12 .0063
Bowel preparation=n (%) 1(2) 47(94) .0001
Intra-operative practices
Analgesia =n (%)
Patientcontrolled intravenous analgesia 50(100) 10(20) .0001
Epidural 4(8) 39(78) .0001
Antibiotics = n (%)
Intra-operative only 28(56) 0(0) .0001
Intra-operative + post-operative 22(43) 50(100) .0001
Nasogastric tube (%) 22(43) 47(94) 0.0001
Peritoneal drain (%) 6(12) 50(100) 0.0001
Post-operative practices
Thromboprophylaxis (days in mean ±SD) 31.68±18.21 7±2.69
UK: United Kingdom, ERAS: Enhanced recovery after surgery
Table-3: Main outcomes.
UK Pakistan p-value
(ERAS group) (Non-ERAS group)
Postoperative Complications =n (%)
Wound infection 7(14.6) 1(2) 0.029
Pyrexia 0(0) 5(10) 0.056
Electrolyte imbalance 7(14) 40(80) 0.0001
Paralytic ileus 7(14) 5(10) 0.5494
Readmissionwithin 14 days 4(8) 1(2) 0.169
Thromboembolism 2(4) 0(0) 0.237
Length of hospital stay (median ±SD) 7±4.03 8.28 ±2.09 0.828
UK: United Kingdom, ERAS: Enhanced recovery after surgery.
For post-operative pain relief, patient-controlled
intravenous analgesia (PCIA) was employed in all ERAS
patients, while an epidural for 48h was used in 39(78%)
non-ERAS.
Postoperative thromboprophylaxis was low-molecular-
weight heparin in both groups, but the duration of use was
different (Table 2).
Wound infection was significantly higher in the ERAS
group, while pyrexia was more prevalent in the non-ERAS
group (p<0.05). Electrolyte imbalance during hospital stay
was significantly high in the non-ERAS group (p<0.05). The
median length of stay was 7 days in the ERAS group
compared to 8 days in non-ERAS group (Table 3). 
Discussion
ERAS literature in advanced gynaecological surgeries,
including gynaecological oncology, is relatively limited.4,7,9
The demographic data and co-morbidities in both groups
in the current study did not show significant differences
except for the presence of diabetes, indicating
comparability.
Hunger, pain, fear and anxiety can all stimulate the stress
response, which, in turn, can aggravate the risk of
complications.10 The ERAS approach can reduce all these
factors, thus reducing the stress reactions to surgery in
these patients.
The policy of ’nothing by mouth after midnight’ before
surgery is the traditional way of preparing patients for
surgery to prevent aspiration during general anaesthesia,
but this is not supported by evidence. Fasting results in
significant detrimental effects by causing patient
discomfort and metabolic changes that can adversely
affect clinical outcomes. A systematic review also
recommended fewer hours of fasting without an increase
in the complication rate.11 This approach is also endorsed
by the guidelines of the European Society of
Anaesthesiology.12 In the current study, patients in the
ERAS group refrained from solids for 6 hours and from
liquids for only 2 hours, while patients in the non-ERAS
group were largely kept on liquids for 48 hours prior to
surgery, and consumed no liquids for almost 12 hours.
Aspiration was not observed with reduced pre-operative
fasting. The unfavourable effects of prolonged fasting
could not be assessed because of the retrospective nature
of the current study.
Pre-operative carbohydrate loading was not practised in
the non-ERAS group, whereas it was given to all ERAS
group patients. Studies have suggested that these
supplements have low osmolality, and, hence, a very short
stomach transit time. Also, these drinks are rapidly
absorbed in the small intestine.13,14
In addition, carbohydrate drinks reduce the patient’s
anxiety and improve hydration in the pre-operative period,
thus enhancing post-operative recovery and wellbeing.13,14
Extensive bowel preparation is part of the traditional pre-
operative preparation for advanced gynaecological
surgeries. The proponents of this approach propose the
feasibility of bowel resection and the decreased risk of
anastomotic leak and infection. However, this has not been
verified in recent literature, and a systematic review of 18
randomised control trials (RCTs) failed to demonstrate any
clinical benefit of bowel preparation.15,16 In our study, no
clinical benefit of bowel preparation was observed.
Electrolyte imbalance was seen more with bowel
preparation. In clinical practice, bowel preparation may be
inappropriate or unsuccessful in patients with ascites
and/or large pelvic-abdominal masses.
Postoperative pain control can be administered by either
epidural or PCIA.17,18 ERAS proponents do not favour
epidural analgesia because of concerns regarding its effects
on post-operative mobility of the patient, a delayed return
of bowel activity and a delay in the removal of the
catheter.19,20
A significantly higher number of patients in the non-ERAS
group had had an NG tube and peritoneal drains inserted
and kept in place in the early post-operative period with
possibly no benefit. These measures were used due to the
belief that gastric emptying is slowed because of the total
omentectomy, and that gastric stasis can be a risk factor for
an increased rate of post-operative nausea, vomiting and
pulmonary complications. This is contrary to the results of
a meta-analysis that showed no effect on the resumption
of bowel function without NG decompression.21
The length of stay (LOS) was almost similar in the current
study groups, which is not consistent with the findings of
other studies related to benign hysterectomy and
colorectal surgery,1,22 where LOS was found to be
significantly reduced in ERAS patients. In the current study,
two patients in the ERAS group had prolonged stay of 18
and 20 days due to pulmonary embolism (PE). Decreased
LOS reduces the cost of inpatient admissions and post-
operative complications. A meta-analysis of colorectal
surgical patients and a study comprising patients from all
surgical disciplines reported that ERAS is cost-effective.23,24
A small sample size and flexibility in adherence to the ERAS
protocol may have added inconsistency to the results of
the indexed study.
Complications and re-admissions were comparable in both
groups in the current study, indicating that implementation
of the protocol was safe, as has been shown by two
RCTs.25,26
The result of the current audit implies that implementation
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of ERAS practices can lead to the improvement of post-
operative outcomes and good functional recovery by
decreasing morbidities and length of stay with no
compromise on patient safety.27
Conclusion
Implementation of ERAS protocol was found to have the
potential to improve post-operative outcomes and good
functional recovery without compromising patient safety.
The protocol can be safely employed in healthcare
institutions in the developing countries.
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